Argus Research maintains a Hold rating on MGM Resorts International (NYSE: MGM), reflecting a balanced view of the company’s growth potential and ongoing challenges. MGM’s U.S.
Argus Research has issued a Buy recommendation for Expedia Group Incorporated (NASDAQ: EXPE), setting a revised target price of $210, indicating a 19% upside potential.
CME Group Incorporated (NASDAQ: CME) stands as a global leader in futures and derivatives trading, benefiting from increased contract volumes amid ongoing interest rate and market volatility.